Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-24

Clinical Trial Update: Follow-up of Study AN004T to Assess the Persistence of AllerT Efficacy During the 2nd to 4th Season After Treatment

View source ↗

Summary

This update reports follow-up results from Study AN004T evaluating the persistence of AllerT efficacy against Birch pollen allergy during seasons 2 through 4 af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AllerT

Snippet

Sponsor: Anergis | Conditions: Birch Pollen Allergy | Status: COMPLETED | Results posted: 2015-06-24